We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$5.13M
2
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$3.96M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$3.79M
4
PTC icon
PTC
PTC
+$3.74M
5
KSU
Kansas City Southern
KSU
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 10.82%
3 Consumer Discretionary 10.62%
4 Healthcare 9.9%
5 Industrials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAD
1901
DELISTED
Rite Aid Corporation
RAD
$75K ﹤0.01%
4,628
– –
DBD
1902
DELISTED
Diebold Nixdorf Incorporated
DBD
$75K ﹤0.01%
5,880
– –
EBSB
1903
DELISTED
Meridian Bancorp, Inc.
EBSB
$75K ﹤0.01%
3,666
-524
-13% -$10.9K
CNOB icon
1904
Center Bancorp
CNOB
$1.79B
$74K ﹤0.01%
2,830
– –
DHT icon
1905
DHT Holdings
DHT
$3.14B
$74K ﹤0.01%
11,353
+1,723
+18% +$10.6K
IVR icon
1906
Invesco Mortgage Capital
IVR
$805M
$74K ﹤0.01%
1,891
– –
OMER icon
1907
Omeros
OMER
$1.24B
$74K ﹤0.01%
4,994
– –
TRIL
1908
DELISTED
Trillium Therapeutics Inc.
TRIL
$74K ﹤0.01%
+7,670
New +$72.2K
ARCH
1909
DELISTED
Arch Resources, Inc.
ARCH
$74K ﹤0.01%
1,294
– –
ENTA icon
1910
Enanta Pharmaceuticals
ENTA
$383M
$73K ﹤0.01%
1,658
– –
GCO icon
1911
Genesco
GCO
$391M
$73K ﹤0.01%
1,150
-178
-13% -$9.65K
MCHB
1912
Mechanics Bancorp
MCHB
$3.78B
$73K ﹤0.01%
1,788
– –
KRNY icon
1913
Kearny Financial
KRNY
$605M
$73K ﹤0.01%
6,113
– –
KRON
1914
DELISTED
Kronos Bio
KRON
$73K ﹤0.01%
3,044
+1,820
+149% +$46.1K
MCRI icon
1915
Monarch Casino & Resort
MCRI
$2.22B
$73K ﹤0.01%
1,097
– –
MGPI icon
1916
MGP Ingredients
MGPI
$379M
$73K ﹤0.01%
1,083
– –
MRSN
1917
DELISTED
Mersana Therapeutics
MRSN
$73K ﹤0.01%
216
+35
+19% +$13.3K
NTR icon
1918
Nutrien
NTR
$32.6B
$73K ﹤0.01%
1,215
– –
PRDO icon
1919
Perdoceo Education
PRDO
$2B
$73K ﹤0.01%
5,930
– –
CUTR
1920
DELISTED
Cutera, Inc.
CUTR
$73K ﹤0.01%
1,488
– –
VRTV
1921
DELISTED
VERITIV CORPORATION
VRTV
$73K ﹤0.01%
1,183
+175
+17% +$9.14K
AVTA
1922
DELISTED
Avantax, Inc. Common Stock
AVTA
$73K ﹤0.01%
4,225
– –
IMKTA icon
1923
Ingles Markets
IMKTA
$1.65B
$72K ﹤0.01%
1,243
– –
NTST
1924
NETSTREIT Corp
NTST
$2.1B
$72K ﹤0.01%
3,112
+1,307
+72% +$28.5K
PLAB icon
1925
Photronics
PLAB
$1.96B
$72K ﹤0.01%
5,437
– –
75 76
77
78 79

Similar funds

AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
EPIM
Evelyn Partners Investment Management London $3.68B AUM 21.15% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.